{"version":"1.0","type":"link","title":"New mechanistic understanding of FXR agonist Vonafexor: inducing sublethal damage of HBV-positive liver cancer cells via promoting anti-tumor immunity.","author_name":"Pan B 외","author_url":"https://prs-insight.online/author/Pan%20B","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/119333","thumbnail_width":1200,"thumbnail_height":630}